Investors

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Apr 14, 2023
Document Date
Apr 12, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Eiger BioPharmaceuticals
Issuer
EIGER BIOPHARMACEUTICALS, INC.
Filer
Vollins James